Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Flow Chemistry Asia 2022
Conferences  \  Flow Chemistry Asia 2022  \  Agenda  \  Andrew Mansfield
RegisterLogin

Andrew Mansfield's Biography


Andrew Mansfield, Flow Chemistry Leader, Syrris

After graduating with a degree in Applied Chemistry Andrew moved into the research sector working for a range of Pharmaceutical companies including Roche, Napp, Parke-Davis and Pfizer. From an early point in his career he began to specialize in new enabling chemical technologies and automation specializing in high throughput synthesis and purification and flow chemistry.

At Pfizer Andrew led the flow chemistry initiative working across research projects and process groups to integrate flow chemistry in Pfizer's workflow. During this time that Andrew undertook an industrial secondment in Prof. Steve Ley's group developing his knowledge in the flow field. After the Pfizer (Sandwich) site closed Andrew took his expertise and ran his own consultancy company developing batch to flow processes, training and working with flow chemistry apparatus manufactures to develop their technology and develop in-house applications. Andrew moved to Syrris in early 2015 first in a technical role to develop flow chemistry applications, moving into Product Management before taking the position as Head of Flow Chemistry Products expanding his role to cover Syrris’ complete flow chemistry portfolio.

Andrew Mansfield Image

How Flow Chemistry Can Impact the Early Drug Discovery Process?

Thursday, 6 October 2022 at 11:00

Add to Calendar ▼2022-10-06 11:00:002022-10-06 12:00:00Europe/LondonHow Flow Chemistry Can Impact the Early Drug Discovery Process?Flow Chemistry Asia 2022 in Tokyo, JapanTokyo, JapanSELECTBIOenquiries@selectbiosciences.com

Flow chemistry is a growing technology in the pharma industry, where it has proved itself invaluable, especially in the process development phase of drug discovery. However, the hit-to-lead and lead-generation phases have been slower to embrace these techniques. The potential benefits are huge, particularly for rapid library generation and challenging chemistries that were previously hard to achieve by traditional batch methods. The content of this presentation looks at how researchers in early drug discovery, who are looking for practical and efficient ways to increase their productivity and shorten the hit-to-lead times can achieve this through the use of flow chemistry techniques.

Add to Calendar ▼2022-10-06 00:00:002022-10-07 00:00:00Europe/LondonFlow Chemistry Asia 2022Flow Chemistry Asia 2022 in Tokyo, JapanTokyo, JapanSELECTBIOenquiries@selectbiosciences.com


Corporate Sponsors